Rise Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Rise Advisors, LLC
- $207 Million
- Q3 2024
A detailed history of Rise Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 500 shares of AMRX stock, worth $4,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$4,125
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$180 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$121 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.25B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...